Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$11.75 +0.44 (+3.86%)
Closing price 03:58 PM Eastern
Extended Trading
$11.59 -0.15 (-1.32%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DRTS vs. ITGR, PLSE, AXGN, TMDX, and IRTC

Should you buy Alpha Tau Medical stock or one of its competitors? Alpha Tau Medical's main competitors and comparable companies include Integer (ITGR), Pulse Biosciences (PLSE), AxoGen (AXGN), TransMedics Group (TMDX), and iRhythm Technologies (IRTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Alpha Tau Medical compare to Integer?

Alpha Tau Medical (NASDAQ:DRTS) and Integer (NYSE:ITGR) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

In the previous week, Alpha Tau Medical had 3 more articles in the media than Integer. MarketBeat recorded 15 mentions for Alpha Tau Medical and 12 mentions for Integer. Integer's average media sentiment score of 0.79 beat Alpha Tau Medical's score of 0.28 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Integer
5 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integer has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A
Integer$1.85B2.33$102.81M$2.9842.61

Integer has a net margin of 5.68% compared to Alpha Tau Medical's net margin of 0.00%. Integer's return on equity of 11.84% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -138.12% -81.68%
Integer 5.68%11.84%5.98%

Alpha Tau Medical has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market. Comparatively, Integer has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alpha Tau Medical presently has a consensus price target of $18.20, indicating a potential upside of 57.44%. Integer has a consensus price target of $113.67, indicating a potential downside of 10.49%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Alpha Tau Medical is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67
Integer
0 Sell rating(s)
11 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.08

Summary

Integer beats Alpha Tau Medical on 9 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

In the previous week, Alpha Tau Medical had 11 more articles in the media than Pulse Biosciences. MarketBeat recorded 15 mentions for Alpha Tau Medical and 4 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.70 beat Alpha Tau Medical's score of 0.28 indicating that Pulse Biosciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pulse Biosciences
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

76.9% of Pulse Biosciences shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 74.0% of Pulse Biosciences shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Alpha Tau Medical has lower revenue, but higher earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pulse Biosciences$1.49M2,189.73-$72.78M-$1.21N/A
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

Pulse Biosciences has a beta of 1.65, indicating that its stock price is 65% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market.

Pulse Biosciences presently has a consensus target price of $66.60, indicating a potential upside of 49.73%. Alpha Tau Medical has a consensus target price of $18.20, indicating a potential upside of 57.44%. Given Alpha Tau Medical's higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than Pulse Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pulse Biosciences
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.86
Alpha Tau Medical
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

Alpha Tau Medical has a net margin of 0.00% compared to Pulse Biosciences' net margin of -5,603.88%. Pulse Biosciences' return on equity of -77.88% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Pulse Biosciences-5,603.88% -77.88% -67.89%
Alpha Tau Medical N/A -138.12%-81.68%

Summary

Pulse Biosciences beats Alpha Tau Medical on 9 of the 16 factors compared between the two stocks.

How does Alpha Tau Medical compare to AxoGen?

AxoGen (NASDAQ:AXGN) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

AxoGen has higher revenue and earnings than Alpha Tau Medical. AxoGen is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AxoGen$266.93M12.57-$15.70M-$0.65N/A
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

80.3% of AxoGen shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 2.4% of AxoGen shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

AxoGen has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to AxoGen's net margin of -11.96%. AxoGen's return on equity of -5.35% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
AxoGen-11.96% -5.35% -4.41%
Alpha Tau Medical N/A -138.12%-81.68%

AxoGen currently has a consensus target price of $58.67, suggesting a potential upside of 4.46%. Alpha Tau Medical has a consensus target price of $18.20, suggesting a potential upside of 57.44%. Given Alpha Tau Medical's higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AxoGen
1 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.75
Alpha Tau Medical
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Alpha Tau Medical had 8 more articles in the media than AxoGen. MarketBeat recorded 15 mentions for Alpha Tau Medical and 7 mentions for AxoGen. AxoGen's average media sentiment score of 0.56 beat Alpha Tau Medical's score of 0.28 indicating that AxoGen is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AxoGen
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

AxoGen beats Alpha Tau Medical on 9 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

TransMedics Group currently has a consensus target price of $113.30, indicating a potential upside of 27.62%. Alpha Tau Medical has a consensus target price of $18.20, indicating a potential upside of 57.44%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, analysts plainly believe Alpha Tau Medical is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.42
Alpha Tau Medical
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

TransMedics Group has a net margin of 19.85% compared to Alpha Tau Medical's net margin of 0.00%. TransMedics Group's return on equity of 13.30% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group19.85% 13.30% 4.93%
Alpha Tau Medical N/A -138.12%-81.68%

In the previous week, Alpha Tau Medical had 10 more articles in the media than TransMedics Group. MarketBeat recorded 15 mentions for Alpha Tau Medical and 5 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.28 beat Alpha Tau Medical's score of 0.28 indicating that TransMedics Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Tau Medical
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

TransMedics Group has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$605.49M5.09$190.29M$3.6924.06
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 6.9% of TransMedics Group shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

TransMedics Group has a beta of 2.14, suggesting that its share price is 114% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market.

Summary

TransMedics Group beats Alpha Tau Medical on 10 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

2.7% of Alpha Tau Medical shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Alpha Tau Medical had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 15 mentions for Alpha Tau Medical and 14 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.67 beat Alpha Tau Medical's score of 0.28 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
4 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alpha Tau Medical has a net margin of 0.00% compared to iRhythm Technologies' net margin of -4.52%. iRhythm Technologies' return on equity of 26.88% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-4.52% 26.88% 4.32%
Alpha Tau Medical N/A -138.12%-81.68%

Alpha Tau Medical has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$747.14M4.29-$44.55M-$1.17N/A
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

iRhythm Technologies has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.28, indicating that its share price is 28% more volatile than the broader market.

iRhythm Technologies currently has a consensus target price of $164.07, suggesting a potential upside of 72.03%. Alpha Tau Medical has a consensus target price of $18.20, suggesting a potential upside of 57.44%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.82
Alpha Tau Medical
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

iRhythm Technologies beats Alpha Tau Medical on 9 of the 16 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.06B$5.75B$7.40B$10.84B
Dividend YieldN/A1.69%2.48%4.74%
P/E Ratio-11.3038.2532.4728.82
Price / SalesN/A5.138.065.37
Price / CashN/A23.4220.7221.66
Price / Book13.354.054.303.50
Net Income-$42.63M$142.56M$3.50B$394.12M
7 Day Performance-12.20%-6.94%-7.93%-8.92%
1 Month Performance-10.26%-8.42%-10.46%-12.02%
1 Year Performance238.53%-2.11%-2.80%-9.62%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
2.8656 of 5 stars
$11.75
+3.9%
$18.20
+54.9%
+207.9%$1.06BN/AN/A121
ITGR
Integer
1.1134 of 5 stars
$126.99
+0.0%
$113.67
-10.5%
+87.9%$4.32B$1.85B21.5211,000
PLSE
Pulse Biosciences
3.5735 of 5 stars
$44.84
-3.3%
$66.60
+48.5%
+241.4%$3.41B$350KN/A116
AXGN
AxoGen
2.0983 of 5 stars
$55.37
0.0%
$57.92
+4.6%
+122.9%$3.31B$225.21MN/A622
TMDX
TransMedics Group
4.288 of 5 stars
$93.91
+1.8%
$113.30
+20.6%
-29.6%$3.20B$605.49M50.67898

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners